Doctor profile · Federal record
Dr. Rebecca Hall, M.D., C.M.
Dermatology Physician (CMS: Dermatology) · Stamford, CT
- NPI 1992970354
- MIPS 0.0 / 100 · 2023
- 18 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1290 Summer St
Stamford, CT 069055360
(203) 325-3576
fax (203) 325-4280
Credentials & registration
- NPI registered
- April 2008 — 18 yrs on file
- Profile last updated
- March 17, 2015
- Year of graduation
- 2008 — 18 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Connecticut #050669
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1992970354. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,884
Distinct HCPCS
10
Medicare allowed
$123,843
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 619 | 434 | $90 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 403 | 133 | $7 | |
17000 |
Destruction of precancer skin growth, 1 growth | 347 | 239 | $59 | |
11102 |
Biopsy of related skin growth, first growth | 213 | 180 | $104 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 149 | 128 | $57 | |
11103 |
Biopsy of related skin growth, each additional growth | 53 | 36 | $52 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 36 | 36 | $112 | |
11900 |
Injection into skin growth, 1-7 growths | 27 | 16 | $54 | |
17261 |
Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 19 | 17 | $144 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 18 | 16 | $173 |
In context: peer comparison
Among 4 peers in Stamford Dermatology Physician, average services per provider: 405. This provider delivers 4.7× the peer median.Open Payments
Industry payments received
All-time total
$1,941
Transactions
73
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Incyte Corporation | 15 | $483.14 | |
| Abbvie INC. | 23 | $448.96 | |
| Janssen Biotech, INC. | 5 | $218.20 | |
| Genzyme Corporation | 5 | $169.60 | |
| Regeneron Healthcare Solutions, INC. | 5 | $121.92 | |
| Arcutis Biotherapeutics, INC. | 4 | $82.71 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $81.94 | |
| Lilly USA, LLC | 3 | $80.31 | |
| Leo Pharma INC. | 3 | $77.21 | |
| Pfizer INC. | 4 | $72.81 | |
| Almirall LLC | 3 | $72.24 | |
| Novartis Pharmaceuticals Corporation | 1 | $17.44 | |
| Amgen INC. | 1 | $14.98 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
454
Patients
259
Total drug cost
$18,535
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 108 | 51 | $2,067 |
| Triamcinolone Acetonide | Generic | 53 | 44 | $324 |
| Clobetasol Propionate | Generic | 35 | 20 | $1,898 |
| Fluorouracil | Generic | 34 | 33 | $2,899 |
| Mupirocin | Generic | 31 | 26 | $311 |
| Metronidazole | Generic | 29 | 19 | $2,722 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 27 | 12 | $1,201 |
| Nystatin | Generic | 23 | 0 | $508 |
| Doxycycline Hyclate | Generic | 21 | 0 | $858 |
| Fluocinonide | Generic | 20 | 16 | $864 |
Frequently asked questions
What is Dr. Rebecca Hall's medical specialty?
Dr. Rebecca Hall practices Dermatology Physician in Stamford, CT.
Where does Dr. Rebecca Hall practice?
Dr. Rebecca Hall practices at 1290 Summer St, Stamford, CT 069055360. Office phone: 2033253576.
What is Dr. Rebecca Hall's NPI?
Dr. Rebecca Hall's National Provider Identifier (NPI) is 1992970354, issued by NPPES.
Does Dr. Rebecca Hall accept Medicare assignment?
Dr. Rebecca Hall does not accept Medicare assignment for all services. Patients may be billed amounts beyond Medicare-allowed charges.
What procedures does Dr. Rebecca Hall commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.